![]() ![]() In general, children are at lower risk of COVID-19. In accordance with the WHO Prioritization Roadmap, the priority remains to prevent deaths by achieving high vaccine coverage (primary series and boosters) in the highest and high priority-use groups. Studies on the safety and efficacy of the vaccine in children aged below 12 are still ongoing. WHO recommends that countries should consider using the vaccine in children aged 6 months to 17 years only when high vaccine coverage with 2 doses has been achieved in the high priority groups as identified in the WHO Prioritization Roadmap.Ĭhildren and adolescents aged 6 months to 17 years of age with comorbidities that put them at significantly higher risk of serious COVID-19 disease, should be offered vaccination, alongside other high-risk groups. This vaccine is authorized for use for those aged 6 months and above, with an adjustment in the recommended dosage in those aged 6 months – 4 years, and those aged 5-11 years. Can children and adolescents take the vaccine? Individuals who developed myocarditis or pericarditis following the first dose of mRNA-1273 vaccine should not receive additional doses of any COVID vaccine unless with the recommendation of their doctor or a healthcare professional. Individuals with a history of severe allergic reaction to any component of the vaccine should not take this or any other mRNA vaccine. WHO does not recommend discontinuing breastfeeding because of vaccination. In addition, vaccine-elicited antibodies have been found in breast milk following vaccination of breastfeeding women, suggesting possible neonatal as well as maternal protection. WHO recommends the use of the vaccine in breastfeeding women as in other adults. Vaccine effectiveness is expected to be similar in breastfeeding women as in other adults. WHO does not recommend delaying pregnancy or terminating pregnancy because of vaccination. WHO does not recommend pregnancy testing prior to vaccination. Given the adverse consequences of COVID-19 during pregnancy and the increasing data supporting a favorable safety profile of mRNA-1273 in pregnancy, WHO recommends the use of mRNA-1273 in pregnant individuals. Should pregnant and breastfeeding women be vaccinated? But individuals may choose to delay vaccination for 3 months following the infection. The Moderna vaccine can be offered to people who have had COVID-19 in the past.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |